Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03030924 · ClinicalTrials.gov registry record
Wearable Suicidal Early Warning System for Adolescents
A clinical trial of Suicide and Adolescent Behavior, sponsored by Oregon Health and Science University.
- Active
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT03030924: Active study of Suicide and Adolescent Behavior, sponsored by Oregon Health and Science University.
NCT03030924 is a study of Suicide and Adolescent Behavior that is active but no longer recruiting, run by Oregon Health and Science University. The registered enrollment target is 250 participants, below the 6,987-participant average among 92 other Suicide trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03030924, a study of Suicide and Adolescent Behavior, is active but no longer recruiting, sponsored by Oregon Health and Science University.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is prospectively enrolling a cohort of adolescent patients who present to the Emergency Department and an inpatient psychiatric adolescent unit with acute suicidality.
Conditions Studied
Interventions
- DEVICE Solace
Study Locations (1)
Oregon
- OHSU - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2026-06-01 |
What the registry record for NCT03030924 still lists
NCT03030924 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 6,987-participant average among 92 other Suicide trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Solace is the first listed.
NCT03030924 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT03030924 about?
NCT03030924 is a clinical study titled "Wearable Suicidal Early Warning System for Adolescents". This study is prospectively enrolling a cohort of adolescent patients who present to the Emergency Department and an inpatient psychiatric adolescent unit with acute suicidality.
What is the current status of trial NCT03030924?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2017-09-18. Estimated completion is 2026-06-01.
What conditions does trial NCT03030924 study?
This clinical trial studies the following conditions: Suicide, Adolescent Behavior.
What interventions are being tested in trial NCT03030924?
The interventions under investigation include: Solace (DEVICE).
Who is sponsoring clinical trial NCT03030924?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03030924 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03030924's enrollment target sits among peer trials
250 28th of 92 higher than 65 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI